Brenda Duarte Acevedo is a seasoned professional with 18 years of extensive experience in the pharmaceutical industry, currently serving as the Private Access Manager at Amgen. In her pivotal role, Brenda leads the business unit focused on private market access, where she is instrumental in...
Brenda Duarte Acevedo is a seasoned professional with 18 years of extensive experience in the pharmaceutical industry, currently serving as the Private Access Manager at Amgen. In her pivotal role, Brenda leads the business unit focused on private market access, where she is instrumental in defining and executing commercial strategies tailored to various segments, including health insurers, health management organizations, oncology centers, hemodialysis clinics, and private hospitals. Her expertise spans a diverse portfolio that includes oncology, hematology, cardiology, nephrology, endocrinology, and biosimilars, making her a key player in ensuring that critical therapies reach patients who need them most.
Brenda's strategic planning skills are complemented by her deep understanding of market access dynamics, allowing her to navigate complex healthcare landscapes effectively. She has successfully spearheaded key projects aimed at enhancing product distribution and logistics, optimizing the supply chain for pharmacies, and implementing innovative access solutions that align with the evolving needs of healthcare providers and patients. Her ability to conduct thorough market analysis and develop targeted marketing strategies has significantly contributed to the sales effectiveness of Amgen's product offerings.
With a strong focus on B2B relationships and project management, Brenda is dedicated to fostering collaborations that drive business growth and improve patient outcomes. Her commitment to excellence and her comprehensive knowledge of the pharmaceutical landscape position her as a valuable asset to Amgen and the broader healthcare community. As she continues to lead initiatives that bridge the gap between innovative therapies and patient access, Brenda remains at the forefront of transforming healthcare delivery in the private sector.
